Development and application of a method to investigate drug-metabolizing enzyme inhibitors using sparteine for probe of cytochrome P450 2D6 and tris(2,2'-bipyridine)ruthenium(II)-electrogenerated chemiluminescence detection.

MLA

Shibano, Yuu, et al. “Development and Application of a Method to Investigate Drug-Metabolizing Enzyme Inhibitors Using Sparteine for Probe of Cytochrome P450 2D6 and Tris(2,2’-Bipyridine)Ruthenium(II)-Electrogenerated Chemiluminescence Detection.” Chemical & Pharmaceutical Bulletin, vol. 59, no. 2, 2011, pp. 249–53. EBSCOhost, https://doi.org/10.1248/cpb.59.249.

APA

Shibano, Y., Taki, S., Miyamoto, A., & Uchikura, K. (2011). Development and application of a method to investigate drug-metabolizing enzyme inhibitors using sparteine for probe of cytochrome P450 2D6 and tris(2,2’-bipyridine)ruthenium(II)-electrogenerated chemiluminescence detection. Chemical & Pharmaceutical Bulletin, 59(2), 249–253. https://doi.org/10.1248/cpb.59.249

Chicago

Shibano, Yuu, Shiwori Taki, Aoi Miyamoto, and Kazuo Uchikura. 2011. “Development and Application of a Method to Investigate Drug-Metabolizing Enzyme Inhibitors Using Sparteine for Probe of Cytochrome P450 2D6 and Tris(2,2’-Bipyridine)Ruthenium(II)-Electrogenerated Chemiluminescence Detection.” Chemical & Pharmaceutical Bulletin 59 (2): 249–53. doi:10.1248/cpb.59.249.